Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in maximal oxygen uptake |
Maximal oxygen uptake (mL/min/kg) was measured by pulmonary gas exchange measurements. The participants performed an incremental treadmill test until voluntary exhaustion in a laboratory, according to a standardized incremental protocol. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in systolic blood pressure |
Systolic blood pressure (mmHg) was measured in a laboratory by an automatic upper arm blood pressure monitor (multiparameter patient monitor, Omron Z207, Kyoto, Japan) according to standardized procedures. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in diastolic blood pressure |
Diastolic blood pressure (mmHg) was measured in a laboratory by an automatic upper arm blood pressure monitor (multiparameter patient monitor, Omron Z207, Kyoto, Japan) according to standardized procedures. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in resting heart rate |
Resting heart rate (bpm) was measured in a laboratory by an automatic upper arm blood pressure monitor (multiparameter patient monitor, Omron Z207, Kyoto, Japan) according to standardized procedures. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body mass |
Whole-body mass was measured by a whole-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm total mass |
Left arm total mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm total mass |
Right arm total mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg total mass |
Left leg total mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg total mass |
Right leg total mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in gynoid total mass |
Gynoid total mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in android total mass |
Android total mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body fat mass |
Whole-body fat mass was measured by a whole-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm fat mass |
Left arm fat mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm fat mass |
Right arm fat mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg fat mass |
Left leg fat mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg fat mass |
Right leg fat mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in gynoid fat mass |
Gynoid fat mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in android fat mass |
Android fat mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body lean mass |
Whole-body lean mass was measured by a whole-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm lean mass |
Left arm lean mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm lean mass |
Right arm lean mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg lean mass |
Left leg lean mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg lean mass |
Right leg lean mass was measured by a regional-body dual- energy X-ray absorptiometry following standard procedures |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body bone mineral density |
Whole-body bone mineral density dual- energy X-ray absorptiometry scans following standard procedures. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body bone mineral content |
Whole-body bone mineral content dual- energy X-ray absorptiometry scans following standard procedures. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in lumbar spine bone mineral density |
Lumbar spine bone mineral density dual- energy X-ray absorptiometry regional scans following standard procedures. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in lumbar spine bone mineral content |
Lumbar spine bone mineral content dual- energy X-ray absorptiometry regional scans following standard procedures. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in femur bone mineral density |
Femur bone mineral density dual- energy X-ray absorptiometry regional scans following standard procedures. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in femur bone mineral content |
Femur bone mineral content dual- energy X-ray absorptiometry regional scans following standard procedures. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in procollagen type-1 amino-terminal propeptide |
Plasma concentrations of biochemical bone turnover markers were analyzed by chemiluminescence method using a fully automated immunoassay system. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in osteocalcin |
Plasma concentrations of biochemical bone turnover markers were analyzed by chemiluminescence method using a fully automated immunoassay system. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in carboxy-terminal type-1 collagen crosslinks |
Plasma concentrations of biochemical bone turnover markers were analyzed by chemiluminescence method using a fully automated immunoassay system. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in sclerostin |
Plasma concentrations of biochemical bone turnover markers were analyzed by chemiluminescence method using a fully automated immunoassay system. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in isometric upper body strength |
Isometric upper body strength was measured by a handgrip dynamometer (kg). |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in postural balance |
Postural balance was evaluated by the number of falls in a single-legged flamingo balance test. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in upper and lower body strength, and coordination |
Upper and lower body strength (N), and coordination (s) tests were measured according to Rikili and Jones ( 2013) standardized protocols. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in aerobic performance |
Aerobic performance (Yo-Yo intermittent endurance level 1 test; YYIE1) (m) was evaluated on an indoor team handball court, acording to a standardized protocol. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in total cholesterol |
Total cholesterol (mg/dl) was determined by an automated analyzer. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in high-density lipoprotein cholesterol |
High-density lipoprotein cholesterol (mg/dl) was determined by an automated analyzer. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in low-density lipoprotein cholesterol |
Low-density lipoprotein cholesterol (mg/dl) was determined by an automated analyzer. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in triglycerides |
Triglycerides (mg/dl) was determined by an automated analyzer. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glycosylated haemoglobin |
Glycosylated haemoglobin (%) was determined by an automated analyzer. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glucose |
Glucose (mg/dl) was determined by an automated analyzer. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in insulin |
Fasting blood insulin (µmol/L) was determined was determined by an automated analyzer. |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in total antioxidant status |
Total antioxidant status (TAS) (mmol/L) was measured in plasma samples using AU5800 (Beckman-Coulter®, USA) |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glutathione reductase |
Glutathione reductase (GR) (U/L) was measured in plasma samples using AU5800 (Beckman-Coulter®, USA) |
Baseline and week 16 |
|
Secondary |
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glutathione peroxidase |
Glutathione peroxidase (GPx) (U/L) was measured in plasma samples using AU5800 (Beckman-Coulter®, USA) |
Baseline and week 16 |
|